CODON OPTIMIZATION FOR HIGH-LEVEL EXPRESSION OF HUMAN ERYTHROPOIETIN (EPO) IN MAMMALIAN-CELLS
Citation
Ch. Kim et al., CODON OPTIMIZATION FOR HIGH-LEVEL EXPRESSION OF HUMAN ERYTHROPOIETIN (EPO) IN MAMMALIAN-CELLS, Gene, 199(1-2), 1997, pp. 293-301
Categorie Soggetti
Genetics & Heredity
SICI code
0378-1119(1997)199:1-2<293:COFHEO>2.0.ZU;2-M
Abstract
Codon bias has been observed in many species. The usage of selective c
odons in a given gene is positively correlated with its expression eff
iciency. As an experimental approach to study codon-usage effects on h
eterologous gene expression in mammalian cells, we designed two human
erythropoietin(EPO) genes, one in which native codons were systematica
lly substituted with codons frequently found in highly expressed human
genes and the other with codons prevalent in yeast genes. Relative pe
rformances of the re-engineered EPO genes were evaluated with various
combinations of promoters and signal leader sequences. Under the compa
rable set of combinations, mature EPO gene with human high-frequency c
odons gave a considerably higher level of expression than that with ye
ast high-frequency codons. However, the levels of EPO expression varie
d, depending on the alternate combinations. Since the promoters and th
e signal leader sequences that we used are known to be equally efficie
nt in gene expression, we hypothesized that the varied expression leve
ls were due to the linear sequence between the promoter and the coding
gene sequence. To test this possibility, we designed the EPO gene wit
h hybrid codon usage in which the 5'-proximal region of the EPO gene w
as synthesized with yeast-biased codons and the rest with human-biased
codons. This codon-usage hybrid EPO gene substantially enhanced the l
evel of EPO transcripts and proteins up to 2.9-fold and 13.8-fold, res
pectively, when compared to the revel reached by the original counterp
art. Our results suggest that the linear sequence between the promoter
and the 5'-proximal region of a gene plays an important role in achie
ving high-level expression in mammalian cells. (C) 1997 Elsevier Scien
ce B.V.